Compendium of Cancer Genome Aberrations

Changes

Volunteer Assignments and Opportunities (view source)

Revision as of 13:50, 28 October 2022

9 bytes added ,  13:50, 28 October 2022
no edit summary
Line 2,272: Line 2,272:  
|Diffuse Paediatric-Type High-Grade Glioma, H3-Wildtype and IDH-Wildtype
 
|Diffuse Paediatric-Type High-Grade Glioma, H3-Wildtype and IDH-Wildtype
 
|Disease
 
|Disease
 +
|Madina Sukhanova
 +
|10/28/2022
 
|
 
|
 +
|PENDING
 
|
 
|
−
|
+
|LS
−
|
  −
|
  −
|
   
|
 
|
 
|2021 template added
 
|2021 template added
Line 2,319: Line 2,319:  
|6/30/2022
 
|6/30/2022
 
|
 
|
−
|PENDING
+
|COMPLETE
 
|
 
|
 
|LS
 
|LS
Line 2,997: Line 2,997:  
!'''Date of Last Editor Review'''
 
!'''Date of Last Editor Review'''
 
!'''Notes'''
 
!'''Notes'''
−
|-|Astrocytoma, IDH-mutant||Disease||
+
|- |Astrocytoma, IDH-mutant||Disease||
 
|
 
|
 
|
 
|
Line 3,051: Line 3,051:  
|
 
|
 
|-
 
|-
−
|Diffuse low-grade glioma, MAPK pathway-altered ||Disease||
+
|Diffuse low-grade glioma, MAPK pathway-altered||Disease||
 
|
 
|
 
|
 
|
Line 3,096: Line 3,096:  
|
 
|
 
|-
 
|-
−
|Pilocytic astrocytoma ||Disease||
+
|Pilocytic astrocytoma||Disease||
 
|
 
|
 
|
 
|
Line 3,285: Line 3,285:  
|
 
|
 
|-
 
|-
−
|Supratentorial ependymoma, ZFTA fusion-positive ||Disease||
+
|Supratentorial ependymoma, ZFTA fusion-positive||Disease||
 
|
 
|
 
|
 
|
Line 4,098: Line 4,098:  
!'''Date of Last Editor Review'''
 
!'''Date of Last Editor Review'''
 
!'''Notes'''
 
!'''Notes'''
−
|-|Usual ductal hyperplasia||Disease||
+
|- |Usual ductal hyperplasia||Disease||
 
|
 
|
 
|
 
|
Line 4,107: Line 4,107:  
|
 
|
 
|-
 
|-
−
|Columnar cell lesions, including flat epithelial atypia ||Disease||
+
|Columnar cell lesions, including flat epithelial atypia||Disease||
 
|
 
|
 
|
 
|
Line 4,143: Line 4,143:  
|
 
|
 
|-
 
|-
−
|Microglandular adenosis ||Disease||
+
|Microglandular adenosis||Disease||
 
|
 
|
 
|
 
|
Line 4,152: Line 4,152:  
|
 
|
 
|-
 
|-
−
|Radial scar / complex sclerosing lesion ||Disease||
+
|Radial scar / complex sclerosing lesion||Disease||
 
|
 
|
 
|
 
|
Line 4,161: Line 4,161:  
|
 
|
 
|-
 
|-
−
|Tubular adenoma ||Disease||
+
|Tubular adenoma||Disease||
 
|
 
|
 
|
 
|
Line 4,170: Line 4,170:  
|
 
|
 
|-
 
|-
−
|Lactating adenoma ||Disease||
+
|Lactating adenoma||Disease||
 
|
 
|
 
|
 
|
Line 4,260: Line 4,260:  
|
 
|
 
|-
 
|-
−
|Atypical lobular hyperplasia ||Disease||
+
|Atypical lobular hyperplasia||Disease||
 
|
 
|
 
|
 
|
Line 4,278: Line 4,278:  
|
 
|
 
|-
 
|-
−
|Ductal carcinoma in situ ||Disease||
+
|Ductal carcinoma in situ||Disease||
 
|
 
|
 
|
 
|
Line 4,314: Line 4,314:  
|
 
|
 
|-
 
|-
−
|Invasive lobular carcinoma ||Disease||
+
|Invasive lobular carcinoma||Disease||
 
|
 
|
 
|
 
|
Line 4,404: Line 4,404:  
|
 
|
 
|-
 
|-
−
|Secretory carcinoma ||Disease||
+
|Secretory carcinoma||Disease||
 
|
 
|
 
|
 
|
Line 4,458: Line 4,458:  
|
 
|
 
|-
 
|-
−
|Hamartoma ||Disease||
+
|Hamartoma||Disease||
 
|
 
|
 
|
 
|
Line 4,467: Line 4,467:  
|
 
|
 
|-
 
|-
−
|Fibroadenoma ||Disease||
+
|Fibroadenoma||Disease||
 
|
 
|
 
|
 
|
Line 4,476: Line 4,476:  
|
 
|
 
|-
 
|-
−
|Phyllodes tumour ||Disease||
+
|Phyllodes tumour||Disease||
 
|
 
|
 
|
 
|
Line 4,485: Line 4,485:  
|
 
|
 
|-
 
|-
−
|Syringomatous tumour ||Disease||
+
|Syringomatous tumour||Disease||
 
|
 
|
 
|
 
|
Line 4,494: Line 4,494:  
|
 
|
 
|-
 
|-
−
|Nipple adenoma ||Disease||
+
|Nipple adenoma||Disease||
 
|
 
|
 
|
 
|
Line 4,530: Line 4,530:  
|
 
|
 
|-
 
|-
−
|Atypical vascular lesions ||Disease||
+
|Atypical vascular lesions||Disease||
 
|
 
|
 
|
 
|
Line 4,575: Line 4,575:  
|
 
|
 
|-
 
|-
−
|Desmoid fibromatosis ||Disease||
+
|Desmoid fibromatosis||Disease||
 
|
 
|
 
|
 
|
Line 4,584: Line 4,584:  
|
 
|
 
|-
 
|-
−
|Inflammatory myofibroblastic tumour ||Disease||
+
|Inflammatory myofibroblastic tumour||Disease||
 
|
 
|
 
|
 
|
Line 4,593: Line 4,593:  
|
 
|
 
|-
 
|-
−
|Schwannoma ||Disease||
+
|Schwannoma||Disease||
 
|
 
|
 
|
 
|
Line 4,602: Line 4,602:  
|
 
|
 
|-
 
|-
−
|Neurofibroma ||Disease||
+
|Neurofibroma||Disease||
 
|
 
|
 
|
 
|
Line 4,629: Line 4,629:  
|
 
|
 
|-
 
|-
−
|Leiomyosarcoma ||Disease||
+
|Leiomyosarcoma||Disease||
 
|
 
|
 
|
 
|
Line 4,638: Line 4,638:  
|
 
|
 
|-
 
|-
−
|Lipoma ||Disease||
+
|Lipoma||Disease||
 
|
 
|
 
|
 
|
Line 4,647: Line 4,647:  
|
 
|
 
|-
 
|-
−
|Angiolipoma ||Disease||
+
|Angiolipoma||Disease||
 
|
 
|
 
|
 
|
Line 4,656: Line 4,656:  
|
 
|
 
|-
 
|-
−
|Liposarcoma ||Disease||
+
|Liposarcoma||Disease||
 
|
 
|
 
|
 
|
Line 4,683: Line 4,683:  
|
 
|
 
|-
 
|-
−
|Follicular lymphoma ||Disease||
+
|Follicular lymphoma||Disease||
 
|
 
|
 
|
 
|
Line 4,692: Line 4,692:  
|
 
|
 
|-
 
|-
−
|Diffuse large B-cell lymphoma ||Disease||
+
|Diffuse large B-cell lymphoma||Disease||
 
|
 
|
 
|
 
|
Line 4,710: Line 4,710:  
|
 
|
 
|-
 
|-
−
|Breast implant-associated anaplastic large cell lymphoma ||Disease||
+
|Breast implant-associated anaplastic large cell lymphoma||Disease||
 
|
 
|
 
|
 
|
Retrieved from "https://ccga.io/index.php/Special:MobileDiff/11713"